Year: 2012
Type: article
Abstract: The echinocandin antifungal drugs inhibit synthesis of the major fungal cell wall polysaccharide β(1,3)-glucan. Echinocandins have good efficacy against Candida albicans but reduced activity against other Candida species, in particular Candida parapsilosis and Candida guilliermondii. Treatment of Candida albicans with a sub-MIC level of caspofungin has been reported to cause a compensatory increase in chitin content and to select for sporadic echinocandin-resistant FKS1 point mutants that also have elevated cell wall chitin. Here we show that elevated chitin in response to caspofungin is a common response in various Candida species. Activation of chitin synthesis was observed in isolates of C. albicans, Candida tropicalis, C. parapsilosis, and C. guilliermondii and in some isolates of Candida krusei in response to caspofungin treatment. However, Candida glabrata isolates demonstrated no exposure-induced change in chitin content. Furthermore, isolates of C. albicans, C. krusei, C. parapsilosis, and C. guilliermondii which were stimulated to have higher chitin levels via activation of the calcineurin and protein kinase C (PKC) signaling pathways had reduced susceptibility to caspofungin. Isolates containing point mutations in the FKS1 gene generally had higher chitin levels and did not demonstrate a further compensatory increase in chitin content in response to caspofungin treatment. These results highlight the potential of increased chitin synthesis as a potential mechanism of tolerance to caspofungin for the major pathogenic Candida species.
DOI: 10.1128/aac.01486-12
Institution: University of Aberdeen
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: chitin synthesis, caspofungin, echinocandin resistance, Candida, Candida albicans, Candida parapsilosis, Candida guilliermondii, Candida tropicalis, Candida krusei, Candida glabrata, FKS1, β-1,3-glucan, calcineurin signaling, protein kinase C signaling, antifungal drug tolerance, fungal cell wall
Open Access status: bronze
Funders: Gilead Sciences, Wellcome Trust
OpenAlex ID: W1995932180
